Uncommon Therapeutics
Latest round
- Seed
Last raised
- Mar 2025
Total raised
- Undisclosed
Investors
- 1
About Uncommon Therapeutics
Founded in 2024 in San Francisco, US, Uncommon Therapeutics develops treatments for rare diseases. The company has one deal recorded so far, with their most recent deal occurring on March 18, 2025.Uncommon Therapeutics specializes in creating therapeutics aimed at addressing the underlying causes of rare neurodevelopmental monogenic diseases, specifically Rett Syndrome, which impacts roughly 1 in 10,000 girls. Utilizing innovative technologies and a multi-modal approach, their drugs are designed to work independently and synergistically, thereby offering comprehensive therapeutic options.Uncommon Therapeutics operates a revenue model centered around partnerships and direct contracts with healthcare institutions. Engaging in B2B transactions, they supply therapeutics to hospitals and clinics focused on rare diseases, while also pursuing collaborations with larger pharmaceutical firms to broaden access to their products. They aim to introduce new products targeted for rare neurodevelopmental disorders by 2026, expanding their reach into markets in Asia and Australia. These initiatives are designed to enhance the effectiveness of their treatments and address unmet medical needs.
Who invested in Uncommon Therapeutics
1 investor across 1 round
See all investors in Uncommon Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 18, 2025
Amount
Undisclosed
Investors
Questions about Uncommon Therapeutics
Who invested in Uncommon Therapeutics?
Uncommon Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Uncommon Therapeutics raised?
Uncommon Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Uncommon Therapeutics last raise money?
Uncommon Therapeutics's most recent round on record is a Seed, in Mar 2025.
What does Uncommon Therapeutics do?
Founded in 2024 in San Francisco, US, Uncommon Therapeutics develops treatments for rare diseases.
Where is Uncommon Therapeutics headquartered?
Uncommon Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like Uncommon Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Uncommon Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Uncommon Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.